Bryan Gillis
Keine laufenden Positionen mehr
Karriereverlauf von Bryan Gillis
Ehemalige bekannte Positionen von Bryan Gillis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | 10.02.2022 | 01.03.2023 |
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 01.08.2018 | 01.02.2022 |
Ausbildung von Bryan Gillis
| Eastern Nazarene College | Undergraduate Degree |
| Boston University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Health Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Private Unternehmen | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Börse
- Insiders
- Bryan Gillis
- Erfahrung
